Related Experiment Videos
Autoregulation in acute focal ischemia. An experimental study
Stroke
|November 1, 1976
Summary
Cerebral autoregulation is impaired by middle cerebral artery occlusion, especially in severely ischemic areas. Autoregulation to increased blood pressure is preserved in some regions, but lost in the most affected zones.
Area of Science:
- Neuroscience
- Cerebrovascular Physiology
- Ischemic Stroke Research
Background:
- Middle cerebral artery occlusion is a common cause of ischemic stroke.
- Cerebral autoregulation is crucial for maintaining stable blood flow to the brain.
- Understanding autoregulation's response to ischemia is vital for developing effective stroke treatments.
Purpose of the Study:
- To assess the autoregulatory capacity of the cerebral circulation during acute middle cerebral artery occlusion in primates.
- To investigate how autoregulation is affected by both increases and decreases in blood pressure under ischemic conditions.
- To determine the relationship between the intensity of ischemia and the degree of autoregulatory impairment.
Main Methods:
- Experimental primates underwent acute middle cerebral artery occlusion.
- Autoregulation was tested by inducing hypertension (aramine) and hypotension (exsanguination).
- Cerebral blood flow and autoregulatory responses were measured in different hemispheric regions.
Main Results:
- Whole hemisphere autoregulation was significantly disturbed by both high and low blood pressure.
- Autoregulation to increased blood pressure was preserved in less ischemic zones but lost in severely ischemic areas (sylvian opercula).
- Autoregulation to decreased blood pressure was impaired across affected areas, with loss intensity dependent on ischemia severity; partial preservation noted above 40% basal flow.
Conclusions:
- Cerebral autoregulation is significantly compromised following middle cerebral artery occlusion, particularly in intensely ischemic regions.
- The degree of autoregulatory loss is directly related to the severity of ischemia.
- Findings support the 'no-reflow' phenomenon in severely ischemic brain tissue, impacting reperfusion potential.